If someone had asked you in winter 2019 your views on gain-of-function research, you would likely have given them a blank look. But since the Covid pandemic, and with the Wall Street Journal revealing in February that the US Department of Energy now thinks Covid-19 is likely to have come from the Wuhan Institute of Virology, gain-of-function research — often conducted to make viruses more infectious and more deadly — is a matter of enormous significance and should be at the forefront of a national conversation about the very real risks it poses.
Already a subscriber? Log in
Get 10 issues
for $20
Subscribe to The Spectator Australia today for the next 10 magazine issues, plus full online access, for just $20.
- Delivery of the weekly magazine
- Unlimited access to spectator.com.au and app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in